Utilities Healthcare Sector

Cipher Pharmaceuticals

Market Cap: CA$318.8m

Operates as a specialty pharmaceutical company in Canada.

Design Therapeutics

Market Cap: US$232.8m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Tenax Therapeutics

Market Cap: US$232.6m

A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.

Jade Biosciences

Market Cap: US$232.4m

Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

Perspective Therapeutics

Market Cap: US$231.8m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

ProKidney

Market Cap: US$230.9m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Optima Health

Market Cap: UK£170.0m

Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.

UroGen Pharma

Market Cap: US$230.5m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Tvardi Therapeutics

Market Cap: US$227.8m

Operates as a biotechnology company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases.

Cresco Labs

Market Cap: CA$309.6m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Instil Bio

Market Cap: US$225.7m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

Y-mAbs Therapeutics

Market Cap: US$224.7m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

Tristel

Market Cap: UK£164.6m

Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

Sight Sciences

Market Cap: US$219.2m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.

BioStem Technologies

Market Cap: US$218.8m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

Monopar Therapeutics

Market Cap: US$217.6m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

scPharmaceuticals

Market Cap: US$217.5m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.

OraSure Technologies

Market Cap: US$216.9m

Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.

Medical Facilities

Market Cap: CA$294.6m

Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.

Dimerix

Market Cap: AU$330.6m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

Fennec Pharmaceuticals

Market Cap: US$212.0m

Operates as a commercial stage biopharmaceutical company in the United States.

Orthocell

Market Cap: AU$325.5m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

Quanterix

Market Cap: US$210.6m

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

CARGO Therapeutics

Market Cap: US$209.8m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

Nuvectis Pharma

Market Cap: US$209.4m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Integrated Diagnostics Holdings

Market Cap: US$209.3m

Operates as a consumer healthcare company that provides medical diagnostics services to patients.

Esperion Therapeutics

Market Cap: US$208.1m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

TurnKey Capital

Market Cap: US$207.6m

HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.

Kodiak Sciences

Market Cap: US$207.4m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

VitaSpring Biomedical

Market Cap: US$207.0m

Focuses on the development of drugs of cell medicine.

Verano Holdings

Market Cap: CA$280.6m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Bioventix

Market Cap: UK£148.9m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

SOPHiA GENETICS

Market Cap: US$200.5m

Operates as a cloud-native software technology company in the healthcare space.

Lyell Immunopharma

Market Cap: US$199.5m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Bright Minds Biosciences

Market Cap: CA$271.8m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Stereotaxis

Market Cap: US$196.9m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.